Breaking News

OctoPlus Renamed Dr. Reddy’s R&D

CoE develops long-acting injectables and liposomal pharmaceutical formulations

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Dr. Reddy’s Laboratories Ltd. has renamed its Dutch research center Octoplus, and affiliated legal entities of OctoPlus, to Dr. Reddy’s Research and Development B.V.   OctoPlus develops long-acting injectables and liposomal pharmaceutical formulations. It was acquired by Dr. Reddy’s in 2013 and became a fully integrated Centre of Excellence for the development of Dr. Reddy’s complex injectables. Dr. Reddy’s R&D, located in the Bio Science Park Leiden, is one o...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters